MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-24-2026
Medtronic PLC Retained Earnings 2011-2026 | MDT
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.5 B | 30.4 B | 30.4 B | 30.2 B | 28.6 B | 28.1 B | 26.3 B | 24.4 B | 23.3 B | 21.7 B | 54.4 B | 19.9 B | 19.1 B | 17.5 B | 16.1 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 54.4 B | 16.1 B | 26.8 B |
Quarterly Retained Earnings Medtronic PLC
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.3 B | 32.1 B | 31.6 B | 31.5 B | 31.3 B | 30.9 B | 30.5 B | 30.4 B | 30.7 B | 30.3 B | 30.3 B | 30.4 B | 29.6 B | 29.8 B | 30.3 B | 30.2 B | 28 B | 29 B | 28.5 B | 28.6 B | 28.2 B | 27.5 B | 27.8 B | 28.1 B | 25.8 B | 27 B | 26.4 B | 26.3 B | 23.4 B | 25.2 B | 24.7 B | 24.4 B | 52.3 B | 25.4 B | 24 B | 23.3 B | 53.8 B | 52.5 B | 52.8 B | 21.7 B | -37.1 M | 53.7 B | 54.2 B | 54.4 B | - | - | - | 19.9 B | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.4 B | -37.1 M | 31.3 B |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.22 | -2.57 % | $ 121 M |  France |
 |
Align Technology
ALGN
|
2.48 B | $ 189.61 | -0.56 % | $ 14.2 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.8 | 0.55 % | $ 1.73 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.63 | -3.04 % | $ 39.2 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.78 | 9.58 % | $ 334 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 26.39 | 3.57 % | $ 223 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 94.87 | 0.52 % | $ 12.8 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.16 | 4.85 % | $ 1.31 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-802 M | $ 5.33 | 3.5 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.19 | -0.12 % | $ 380 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 64.2 | -1.45 % | $ 3.5 B |  Britain |
 |
LENSAR
LNSR
|
-178 M | $ 5.09 | -3.23 % | $ 60.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.27 | -0.78 % | $ 51.7 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.84 | 1.88 % | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.06 | 0.95 % | $ 18 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 38.34 | 2.24 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 56.31 | -0.07 % | $ 1.65 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 86.02 | 1.37 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
-259 M | $ 9.0 | -1.85 % | $ 6.03 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 84.15 | 5.56 % | $ 49.2 B | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.43 | 2.39 % | $ 507 M | USA |
 |
Nevro Corp.
NVRO
|
-813 M | - | - | $ 217 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.82 | 5.52 % | $ 34.3 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.7 | 12.54 % | $ 32.9 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |